|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
Introduction and Objective.
The US published (1997) minimal standards to assess the efficacy of therapy for UI . The standards were developed by a US committee and were approved by American Urological Society. The US intended that clinical and basic science research studies in UI would adopt these standards and report their findings according to this format. The objective of our study was to evaluate compliance with these standards in recent UI research studies.
Methods.
A
Medline search was conducted for all articles in which outcomes
of treatment for UI were reported (Nov 1997 - October 1999). A table
containing the minimal recommended standards was developed which
included pre-treatment data on: (a) micturition history; (b) structured
physical exam (PE); (c) neurological and vaginal exams; (c) micturition
diary; (d) pad test; (e) urodynamic studies (UDS). Post-treatment
data were recommended on the same categories (a-e) as well as Quality
of Life (QOL), Uroflowmetry and post-void residual (PVR). The data
reported in each article were extracted and compared to the recommended
standards. Compliance rates for each data field was calculated by
percentages for (a) the individual article and (b) overall compliance
rate among all articles. Not all data standards appeared relevant
to some studies, so the denominator varied.
Results.
A total of 45 articles that reported treatment
for UI were selected. The treatments included various sling procedures,
injectables, pharmacological treatments, and mechanical valves.
The compliance rate for individual article ranges from 25% -65%
of recommended data. Table below shows the overall compliance rate
for each data field among all the reports.
|
Pre-treatment: Compliance |
MictHist 50% |
P.E. 60% |
NeuroEx 20% |
VagEx 63% |
Diary 30% |
PadTest 25% |
UDS 58% |
|
|
Post-treatment |
MictHist 27% |
P.E. 63% |
Diary 25% |
PadTest 30% |
UDS 12% |
Uroflow 43% |
PVR 43% |
QOL 15% |
Conclusions.
We conclude that there is far less than optimal
reporting of outcomes for treatment of UI per the recommendations
of the Urodynamic Society. This low compliance makes standardized
evaluation of treatment outcomes difficult if not impossible. Without
the ability to standardize evaluation of published studies fair
and objective comparisons cannot be made. Research in UI should
be designed to accommodate national guidelines.